Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hackensack Meridian Health
Allogene Therapeutics
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Thomas Jefferson University
Fred Hutchinson Cancer Center
University of Pittsburgh
University of Illinois at Chicago